...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith prezzy

Good points tada and SF.

I see no reason why Don is not giving us a thorough update.

Regards

Tada

Share
New Message
Please login to post a reply